We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Milestone Achieved in the Regeneration of Brain Cells

By Biotechdaily staff writers
Posted on 04 Sep 2007
A research group has achieved an additional step for the potential replacement of damaged brain cells after injury or disease: functional nerve cells can be generated from astroglia, a type of supportive cells in the brain by means of dedicated regulator proteins.

The majority of cells in the human brain are not nerve cells but star-shaped glia cells, the so-called astroglia, according to the researchers, from the Institute of Stem Cell Research of the GSF-National Research Center for Environment and Health (Neuherberg, Germany), and the Ludwig Maximilians University (Munich, Germany). More...
"Glia means glue,” explained Prof. Dr. Magdalena Götz, from GSF-National Research Center for Environment and Health. "As befits their name, until now these cells have been regarded merely as a kind of ‘putty' keeping the nerve cells together.”

A couple of years ago, the researchers were able to confirm that these glia cells function as stem cells during development. This means that they are able to differentiate into functional nerve cells. However, this ability gets lost in later stages of development, so that even after an injury to the adult brain, glial cells are unable to generate any more nerve cells.

To be able to reverse this development, the team evaluated what molecular switches are needed for the creation of nerve cells from glial cells during development. These regulator proteins are introduced into glial cells from the postnatal brain, which then respond by triggering the expression of neuronal proteins.

In his current study, Dr. Benedikt Berninger, from the Ludwig Maximilians University, was able to demonstrate that single regulator proteins were quite sufficient to generate new functional nerve cells from glia cells. The transition from glia-to-neuron could be tracked live with a time-lapse microscope. It was shown that glia cells needed time for the reprogramming until they take the normal shape of a nerve cell. "These new nerve cells then have also the typical electrical properties of normal nerve cells,” emphasized Dr. Berninger. "We could show this by means of electrical recordings.”

"Our results are very encouraging, because the generation of correctly functional nerve cells from postnatal glia cells is an important step on the way to be able to replace functional nerve cells also after injuries in the brain,” stressed Dr. Götz.

The researchers published their findings in the August 8, 2007, issue of the Journal of Neuroscience.


Related Links:
Institute of Stem Cell Research of the GSF-National Research Center for Environment and Health
Ludwig Maximilians University

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.